Furthermore, in the Aβ-predominant ADNC-MSA variant, tau pathology, which is the major reason for accelerated cognitive impairment in cases with typical ADNC,34,49,55 does not have an impact on the clinical progression. This evidence concerns the gene MAPT and Cognitive impairment.